Lymphoma Basics - Tiny Tumors, Big Trouble
- Malignant neoplasms of lymphocytes or their precursors, typically arising in lymphoid tissues.
- Two major categories: Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL).
- HL: Characterized by presence of Reed-Sternberg (RS) cells; often localized, contiguous spread.
- NHL: More common, diverse group of B-cell, T-cell, NK-cell origin; often disseminated.
- Staging: Ann Arbor classification (Stages I-IV, with A/B symptoms).

⭐ Hodgkin Lymphoma classically presents with a bimodal age distribution, peaking at 15-35 years and again at >50 years anco
Hodgkin's Lymphoma - Reed's Rogue Roster
⭐ Reed-Sternberg (RS) cells are pathognomonic, appearing as large cells with bilobed or multiple nuclei and prominent eosinophilic nucleoli ("owl-eye" appearance).
- Age: Bimodal distribution (15-35 years and >50 years).
- Presentation: Painless lymphadenopathy (often cervical/supraclavicular), contiguous spread. "B" symptoms: unexplained fever, drenching night sweats, weight loss >10% over 6 months.
- 📌 RS Cell "Rogues": Owl eyes, With Lacunar variants (Nodular Sclerosis type), CD30 & CD15 positive.
- Key Subtypes:
- Nodular Sclerosis (most common, young females, good prognosis)
- Mixed Cellularity (EBV association, intermediate prognosis)
- Lymphocyte-Rich (best prognosis)
- Lymphocyte-Depleted (worst prognosis, HIV association)

Non-Hodgkin's Lymphoma - Nasty Network Nuisance
- Aggressive lymphoid malignancies, commoner than HL in kids. Often extranodal.
- Key Subtypes & Features:
- Burkitt Lymphoma (BL):
- Aggressive B-cell. Endemic (jaw, EBV) & Sporadic (abdomen).
- Histology: "Starry sky" appearance.
- Genetics: t(8;14) translocation involving MYC gene.
⭐ Burkitt Lymphoma is the fastest growing human tumor and associated with t(8;14).
- Lymphoblastic Lymphoma (LBL):
- Mostly T-cell (85-90%).
- Mediastinal mass (SVC risk), LAD. Can → ALL.
- Diffuse Large B-cell Lymphoma (DLBCL):
- Aggressive B-cell type.
- Anaplastic Large Cell Lymphoma (ALCL):
- ALK+ (t(2;5)). Nodes, skin, bone. 'Hallmark' cells.
- Burkitt Lymphoma (BL):
- Clinical Presentation: Rapid mass (abdomen, mediastinum, H&N), LAD. B-symptoms < HL. Emergencies (SVC, TLS) common.
- Diagnosis & Management:
- 📌 Tx: CHOP-like chemo + Rituximab (B-cell). CNS prophylaxis vital.
Clues & Confirmation - Spotting Sneaky Cells
- Clinical Suspicion:
- Painless, firm lymphadenopathy (rubbery, matted).
- B-symptoms: Fever (>38°C), drenching night sweats, weight loss (>10%/6mo). 📌 "B" for Bad prognosis.
- Mediastinal mass (HL, T-LBL): cough, dyspnea.
- Abdominal symptoms (Burkitt): pain, mass.
- Diagnostic Workup:
- Labs: CBC, ESR, LDH (↑), Uric acid.
- Imaging: CXR, CT (staging), PET-CT (FDG-avid).
- Biopsy is KEY:
⭐ Excisional lymph node biopsy is crucial for accurate diagnosis and subtyping.
- Bone marrow & CSF analysis (staging, high-risk NHL).
- HPE & IHC:
- HL: Reed-Sternberg cells (CD30+, CD15+).
- NHL: Specific markers (e.g., Burkitt: t(8;14), Starry sky; Lymphoblastic: TdT+).
High‑Yield Points - ⚡ Biggest Takeaways
- Hodgkin Lymphoma (HL): Reed-Sternberg cells are pathognomonic. Nodular Sclerosis is the most common subtype. Presents with painless lymphadenopathy.
- Non-Hodgkin Lymphoma (NHL): More common, aggressive. Key types: Burkitt (t(8;14), starry sky, abdominal/jaw mass) & Lymphoblastic (mediastinal mass).
- B symptoms (fever, night sweats, weight loss) are important prognostic factors, especially in HL.
- Ann Arbor staging for HL. NHL often has extranodal involvement and rapid dissemination.
- Chemotherapy is the primary treatment; radiotherapy is used cautiously to minimize late effects.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app